Volume 11, Issue 5, Pages (May 2010)

Slides:



Advertisements
Similar presentations
Volume 6, Issue 8, Pages (August 2017)
Advertisements

Volume 14, Issue 2, Pages (August 2011)
Volume 9, Issue 3, Pages (March 2009)
Volume 12, Issue 1, Pages (July 2010)
Volume 15, Issue 5, Pages (May 2012)
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Volume 20, Issue 3, Pages (July 2017)
Is Energy Deficiency Good in Moderation?
Volume 1, Issue 2, Pages (February 2005)
Volume 11, Issue 1, Pages (January 2010)
Volume 22, Issue 8, Pages (February 2018)
Won Hee Choi, Jiyun Ahn, Chang Hwa Jung, Jung Sook Seo, Tae Youl Ha 
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 8, Issue 4, Pages (October 2008)
Pascal Ferré, Fabienne Foufelle  Cell Metabolism 
Volume 20, Issue 4, Pages (October 2014)
Irs1 Serine 307 Promotes Insulin Sensitivity in Mice
Volume 14, Issue 2, Pages (August 2011)
Beneficial Effects of Subcutaneous Fat Transplantation on Metabolism
Volume 9, Issue 4, Pages (April 2009)
Volume 22, Issue 3, Pages (March 2015)
Volume 15, Issue 2, Pages (February 2012)
Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk  Jennifer H. Stern, Joseph M. Rutkowski,
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Volume 26, Issue 5, Pages e3 (November 2017)
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Volume 9, Issue 6, Pages (June 2009)
Imbalanced Insulin Actions in Obesity and Type 2 Diabetes: Key Mouse Models of Insulin Signaling Pathway  Tetsuya Kubota, Naoto Kubota, Takashi Kadowaki 
Cristoforo Silvestri, Vincenzo Di Marzo  Cell Metabolism 
Volume 18, Issue 5, Pages (November 2013)
Volume 9, Issue 3, Pages (March 2009)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
Volume 13, Issue 3, Pages (March 2011)
Volume 1, Issue 1, Pages (January 2005)
Volume 16, Issue 4, Pages (October 2012)
Volume 10, Issue 5, Pages (November 2009)
Volume 10, Issue 1, Pages (July 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 9, Issue 1, Pages (January 2009)
Volume 5, Issue 5, Pages (May 2007)
Varman T. Samuel, Gerald I. Shulman  Cell Metabolism 
Volume 22, Issue 2, Pages (August 2015)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism  Barbara B. Kahn, Thierry Alquier, David Carling,
Syntaxin 4 Overexpression Ameliorates Effects of Aging and High-Fat Diet on Glucose Control and Extends Lifespan  Eunjin Oh, Richard A. Miller, Debbie C.
Volume 6, Issue 1, Pages (July 2007)
Volume 2, Issue 2, Pages (August 2005)
Fueling Up Skeletal Muscle to Reduce Obesity: A TrkB Story
Volume 10, Issue 6, Pages (December 2009)
Prevention of Steatosis by Hepatic JNK1
Volume 8, Issue 5, Pages (November 2008)
Volume 15, Issue 2, Pages (February 2012)
Volume 12, Issue 6, Pages (December 2010)
Volume 14, Issue 6, Pages (February 2016)
A Non-invasive Method to Assess Hepatic Acetyl-CoA In Vivo
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Volume 14, Issue 2, Pages (August 2011)
AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
Volume 22, Issue 2, Pages (August 2015)
Lipin, a lipodystrophy and obesity gene
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 4, Issue 5, Pages (November 2006)
Adiponectin: Starving for Attention
Clémence Blouet, Hiraku Ono, Gary J. Schwartz  Cell Metabolism 
Adipose Fatty Acid Oxidation Is Required for Thermogenesis and Potentiates Oxidative Stress-Induced Inflammation  Jieun Lee, Jessica M. Ellis, Michael J.
Volume 14, Issue 2, Pages (August 2011)
Of Mice and Men: Not ExAKTly the Same?
Nicotinamide Mononucleotide, a Key NAD+ Intermediate, Treats the Pathophysiology of Diet- and Age-Induced Diabetes in Mice  Jun Yoshino, Kathryn F. Mills,
Volume 26, Issue 1, Pages 1-10.e7 (January 2019)
Volume 6, Issue 6, Pages (December 2007)
Presentation transcript:

Volume 11, Issue 5, Pages 402-411 (May 2010) Resistance to High-Fat Diet-Induced Obesity and Insulin Resistance in Mice with Very Long-Chain Acyl-CoA Dehydrogenase Deficiency  Dongyan Zhang, Jennifer Christianson, Zhen-Xiang Liu, Liqun Tian, Cheol Soo Choi, Susanne Neschen, Jianying Dong, Philip A. Wood, Gerald I. Shulman  Cell Metabolism  Volume 11, Issue 5, Pages 402-411 (May 2010) DOI: 10.1016/j.cmet.2010.03.012 Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 1 Body Weight and Food Intake during High-Fat Feeding and Calorimetry Measurements (A) VLCAD−/− mice have significantly lower body weight (p < 0.05) than WT mice when fed a high-fat diet ad lib for 100 days. (B) VLCAD−/− mice have significantly lower food intake (p < 0.05) as compared to WT mice fed a high-fat diet ad lib for the first 2 weeks of feeding. (C and D) VLCAD−/− mice have (C) significantly lower RQ (p < 0.001) and (D) lower energy expenditure (p < 0.02) as compared to WT controls measured over 24 hr. RQ and energy expenditure measurements were performed on mice pair-fed high-fat diet for 3 months. In both groups, n = 7. Values are mean ± SEM. Cell Metabolism 2010 11, 402-411DOI: (10.1016/j.cmet.2010.03.012) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 2 VLCAD−/− Mice Are Resistant to High-Fat Diet-Induced Insulin Resistance (A–D) VLCAD−/− mice are resistant to high-fat diet-induced insulin resistance, as demonstrated by (A) a significantly higher glucose infusion rate, (B) significantly higher whole-body glucose uptake (Rd), (C) significantly higher insulin-mediated suppression of hepatic glucose production (HGP), and (D) a significantly higher skeletal muscle glucose uptake as compared to WT controls pair-fed high-fat diet. (E–H) The downstream effects include significantly increased Akt2 activity in the liver (E) and muscle (F) of VLCAD−/− mice. VLCAD−/− mice also had improved glucose tolerance during IPGTT, as shown by a significantly lower glucose curve (G) as compared to WT, while the insulin curve was also trending lower (H). ∗p < 0.05; ∗∗p < 0.01. In both groups, n = 7; both groups were pair-fed the high-fat diet. Values are mean ± SEM. Cell Metabolism 2010 11, 402-411DOI: (10.1016/j.cmet.2010.03.012) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 3 nPKC and Fatty Acid Metabolite Measurements in Liver and Skeletal Muscle (A) Protein kinase Cɛ or θ membrane translocation (activation) in liver and muscle of VLCAD−/− mice were significantly decreased as compared to WT controls. (B and C) (B) Diacylglycerol (DAG) and (C) triglyceride (TG) concentrations in liver were significantly lower in the VLCAD−/− mice. (D) VLCAD−/− mice had significantly higher total acyl-CoA concentrations in liver (p < 0.01) and muscle. (E) There were no significant differences in the liver ceramide concentrations. (F) Liver malonyl-CoA was significantly lower in VLCAD−/− mice. (G) Liver acyl-CoA profile. Open bars are WT, and black-filled bars indicate VLCAD−/− mice. ∗p < 0.05; ∗∗p < 0.01. In both groups, n = 7; both groups were pair-fed the high-fat diet. Values are mean ± SEM. Cell Metabolism 2010 11, 402-411DOI: (10.1016/j.cmet.2010.03.012) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 4 AMPK Activity and Phospho-Acetyl-CoA Carboxylase (A and B) AMPK activity is significantly elevated in (A) VLCAD−/− liver and skeletal muscle, but not in (B) LCAD−/− liver and skeletal muscle. (C and D) VLCAD−/− mice have significantly increased phosphorylated (inactivated form) ACC in both (C) liver and (D) skeletal muscle. (E) Fatty acid oxidation is significantly increased in VLCAD−/− mouse liver, BAT, and skeletal muscle. ∗p < 0.05; ∗∗∗p < 0.001. In all groups, n = 7. Values are mean ± SEM. Cell Metabolism 2010 11, 402-411DOI: (10.1016/j.cmet.2010.03.012) Copyright © 2010 Elsevier Inc. Terms and Conditions

Figure 5 Schematic Summary of Increased Fatty Acid Oxidation and Insulin Sensitivity in High-Fat Diet-Fed VLCAD−/− Mice We hypothesize that, due to the build-up of long-chain fatty acids in the mouse VLCAD-deficient state with enzymatic compensation provided by intact LCAD activity, there is a stimulation of fatty acid oxidation via (1) direct activation of AMPK and (2) stimulation of PPAR-α with the collective downstream activation of mitochondrial fatty acid oxidation. The net effect is a resistance in the VLCAD −/− mice to the build-up of DAG and the insulin-resistant state found in the high-fat diet-fed WT mice. Cell Metabolism 2010 11, 402-411DOI: (10.1016/j.cmet.2010.03.012) Copyright © 2010 Elsevier Inc. Terms and Conditions